Increased ventral striatal monoaminergic innervation in Tourette syndrome
暂无分享,去创建一个
Thomas E. Nichols | S. Minoshima | R. Albin | N. Bohnen | R. Koeppe | S. Minoshima | K. Frey | K. Wernette | M. Kilbourn | P. Meyer | R.L. Albin | R.A. Koeppe | N.I. Bohnen | T.E. Nichols | P. Meyer | K. Wernette | M.R. Kilbourn | K.A. Frey
[1] H. L. Wiener,et al. Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier. , 1989, European journal of pharmacology.
[2] A. Braun,et al. The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. II: Relationships between Regional Cerebral Metabolism and Associated Behavioral and Cognitive Features of the Illness , 1995, Neuropsychopharmacology.
[3] H. Singer,et al. Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome , 1991, Annals of neurology.
[4] E. Richardson. Neuropathological studies of Tourette syndrome. , 1982, Advances in neurology.
[5] K. Frey,et al. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. , 1995, European journal of pharmacology.
[6] M. Mintun,et al. Integrated and automated data analysis method for neuronal activation studies using O-15 water PET , 1993 .
[7] R. Albin,et al. Striatal presynaptic monoaminergic vesicles are not increased in Tourette’s syndrome , 1999, Neurology.
[8] M. Ernst,et al. High presynaptic dopaminergic activity in children with Tourette's disorder. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[9] R. Kurlan. Handbook of Tourette's syndrome and related tic and behavioral disorders , 1993 .
[10] Yun Zhou,et al. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. , 2002, The American journal of psychiatry.
[11] Karl J. Friston,et al. A unified statistical approach for determining significant signals in images of cerebral activation , 1996, Human brain mapping.
[12] M. Caron,et al. OCD-Like Behaviors Caused by a Neuropotentiating Transgene Targeted to Cortical and Limbic D1+ Neurons , 1999, The Journal of Neuroscience.
[13] V. Sossi,et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease , 2000, Annals of neurology.
[14] A. Boulton,et al. Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. , 1993, European journal of pharmacology.
[15] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[16] E Stern,et al. A functional neuroanatomy of tics in Tourette syndrome. , 2000, Archives of general psychiatry.
[17] E. Chee,et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome , 1993, Neurology.
[18] Suzanne N. Haber,et al. Gilles de la Tourette's syndrome A postmortem neuropathological and immunohistochemical study , 1986, Journal of the Neurological Sciences.
[19] A. Kelley,et al. Differential Behavioral Responses to Dopaminergic Stimulation of Nucleus Accumbens Subregions in the Rat , 1997, Pharmacology Biochemistry and Behavior.
[20] Guy Marchal,et al. Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.
[21] K. Berridge,et al. Fear and Feeding in the Nucleus Accumbens Shell: Rostrocaudal Segregation of GABA-Elicited Defensive Behavior Versus Eating Behavior , 2001, The Journal of Neuroscience.
[22] M. Robertson,et al. Tourette syndrome, associated conditions and the complexities of treatment. , 2000, Brain : a journal of neurology.
[23] S. Haber,et al. Basal ganglia peptidergic staining in Tourette syndrome. A follow-up study. , 1992, Advances in neurology.
[24] D. Kuhl,et al. [3H]methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity , 1995, Neuroscience.
[25] G. N. Brito. A neurobiological model for Tourette syndrome centered on the nucleus accumbens. , 1997, Medical Hypotheses.
[26] J. O. Schenk,et al. The Striatal Transporter for Dopamine in the Rat May Be Kinetically Up‐Regulated Following 3 Weeks of Withdrawal from Cocaine Self‐Administration , 1994, Journal of neurochemistry.
[27] K. Berridge,et al. The Neuroscience of Natural Rewards: Relevance to Addictive Drugs , 2002, The Journal of Neuroscience.
[28] D. R. Weinberger,et al. Cerebral morphometric abnormalities in Tourette's syndrome , 1995, Neurology.
[29] D E Kuhl,et al. Assessment of Extrastriatal Vesicular Monoamine Transporter Binding Site Density Using Stereoisomers of [11C]Dihydrotetrabenazine , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] S. Smith‐Roe,et al. Coincident Activation of NMDA and Dopamine D1Receptors within the Nucleus Accumbens Core Is Required for Appetitive Instrumental Learning , 2000, The Journal of Neuroscience.
[31] B. Peterson,et al. Reduced basal ganglia volumes in Tourette's syndrome using three‐dimensional reconstruction techniques from magnetic resonance images , 1993, Neurology.
[32] C. Tanner,et al. A rating scale for Gilles de la Tourette's syndrome , 1987, Neurology.
[33] M R Kilbourn,et al. A simple synthesis of [11C]dihydrotetrabenazine (DTBZ). , 1997, Nuclear medicine and biology.
[34] D. Pauls. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. , 1999, American journal of human genetics.
[35] R. Koeppe,et al. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] A. Gjedde,et al. Regulation of DOPA Decarboxylase Activity in Brain of Living Rat , 1995, Journal of neurochemistry.
[37] A. Antonini,et al. The metabolic anatomy of Tourette's syndrome , 1997, Neurology.
[38] C. I. Connolly,et al. Building neural representations of habits. , 1999, Science.
[39] Richardson Ep. Neuropathological studies of Tourette syndrome. , 1982 .
[40] Reinhard Dengler,et al. Dopamine transporter binding in Gilles de la Tourette syndrome , 2000, Journal of Neurology.
[41] D E Kuhl,et al. Equilibrium versus Compartmental Analysis for Assessment of the Vesicular Monoamine Transporter Using (+)-α-[11C]Dihydrotetrabenazine (DTBZ) and Positron Emission Tomography , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[42] J. Hubble,et al. Aromatic L‐Amino Acid Decarboxylase Activity of Mouse Striatum Is Modulated via Dopamine Receptors , 1993, Journal of neurochemistry.
[43] M. Trimble,et al. A volumetric MRI study of Gilles de la Tourette's syndrome , 1997, Neurology.
[44] A. Anderson,et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. , 1998, Archives of general psychiatry.
[45] J. W. Aldridge,et al. Coding of Serial Order by Neostriatal Neurons: A “Natural Action” Approach to Movement Sequence , 1998, The Journal of Neuroscience.
[46] V M Haughton,et al. Abnormal cerebral activation associated with a motor task in Tourette syndrome. , 1998, AJNR. American journal of neuroradiology.